WHO Recommends Use of Monoclonal Antibodies in Ebola Treatment
FDA Approved AUVELITY for Major Depressive Disorder in Adults
FDA Approves Mirena for 8 Years
Integrating Real-World and Clinical Trial Data to Improve Patient Outcomes
FDA Expands Emergency Use Authorization for Novavax COVID Vaccine in Kids
Biden Administration Secures COVID-19 Booster Shots for Use This Fall
Judge Rules against CVS, Walgreens, and Walmart in Ohio Opioid Case
FDA Approves Cell-Based Gene Therapy for Patients with Beta Thalassemia
FDA Approves the Sale of Hearing Aids over the Counter
CVS Implements Time Delay Safes for Controlled Substances
Merck & Co Manufacturing Mishap Leads to Carcinogen in Diabetes Medication
California Allots $100 Million to Produce Insulin, Improving Access
FDA Considers Dividing Monkeypox Vaccine Doses
Hormonal Male Birth Control Product Reaches Late-Phase Clinical Trials
Update on FDA Review and Enforcement of Non-Tobacco Nicotine Products
Fourth COVID Shot Reduced the Risk of Infection by 12.9%
Pfizer Buys Global Blood Therapeutics for $5.4B, Continues Acquisition Splurge
Antibiotic Overprescription Is Associated with Worse CKD Outcomes
Lyons Magnus Recalls Products due to Microbial Contamination
COVID-19 Vaccination Reduced the Risk of Reinfection by Approximately 50%
Fall COVID Vaccine Boosters Could Prevent over 100,000 Deaths
Merck & Co.‘s $40B Acquisition of Pharmaceutical Company Seagen
$4.25 Billion Opioid Settlement by Teva Pharmaceuticals
HHS Statement on FDA Approval of Bavarian Nordic Monkeypox Vaccine
Astellas and Seagen Announce Results on a Drug for Urothelial Cancer